SCOPUS 정보 검색 플랫폼

Volumn 20, Issue 1, 2002, Pages 109-112

Vitamin D analogs for the treatment of secondary hyperparathyroidism

(2) Slatopolsky, Eduardo a Brown, Alex J a

a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE (United States)

Author keywords

Calcifications; Calcium; Calcium x phosphate product; Parathyroid hormone; Phosphorus; Uremia; Vitamin D; Vitamin D analogs

Indexed keywords

22 OXACALCITRIOL; CALCITRIOL; CALCIUM; DOXERCALCIFEROL; PARATHYROID HORMONE; PARICALCITOL; PHOSPHORUS; VITAMIN D DERIVATIVE; 1 ALPHA HYDROXYERGOCALCIFEROL; 1 ALPHA-HYDROXYERGOCALCIFEROL; DRUG DERIVATIVE; ERGOCALCIFEROL; VITAMIN D;

ARTICLE; BONE METABOLISM; CALCIUM ABSORPTION; CALCIUM MOBILIZATION; CATTLE; CHEMICAL MODIFICATION; CLINICAL TRIAL; DOSE TIME EFFECT RELATION; DRUG ACTIVITY; DRUG EFFECT; DRUG EFFICACY; DRUG MECHANISM; DRUG POTENCY; DRUG SELECTIVITY; DRUG STRUCTURE; HORMONE SYNTHESIS; HUMAN; HYPERCALCEMIA; HYPERPHOSPHATEMIA; INTESTINE ABSORPTION; NONHUMAN; PARATHYROID CELL; PARATHYROID GLAND; PARATHYROID HORMONE RELEASE; PRIORITY JOURNAL; SECONDARY HYPERPARATHYROIDISM; STRUCTURE ACTIVITY RELATION; ANIMAL; BLOOD; HYPERPARATHYROIDISM; KIDNEY FAILURE; RAT; REVIEW;

ANIMAL; CALCIUM; ERGOCALCIFEROLS; HUMAN; HYPERPARATHYROIDISM; KIDNEY FAILURE; PHOSPHORUS; RATS; VITAMIN D; ANIMALS; HUMANS;

EID: 0036007333 PISSN: 02535068 EISSN: None Source Type: Journal
DOI: 10.1159/000046993 Document Type: Article

Times cited : (26)

References (15)

1
- 0006519608
- Regulation by vitamin D metabolites of messenger RNA for pre-pro-parathyroid hormone in isolated bovine parathyroid cells
- (1985) Proc Natl Acad Sci USA , vol.82 , pp. 4270-4273
- Silver, J.¹ Russell, J.² Sherwood, L.M.³

2
- 0022350156
- 3 suppresses PTH secretion from bovine parathyroid cells in tissue culture
- (1985) Endocrinology , vol.117 , pp. 2114-2119
- Cantley, L.K.¹ Russell, J.² Lettieri, D.³ Sherwood, L.M.⁴

3
- 0021748474
- Marked suppression of secondary hyperparathyroidism by intravenous administration of 1,25-dihydroxychole-calciferol in uremic patients
- (1984) J Clin Invest , vol.74 , pp. 2136-2143
- Slatopolsky, E.¹ Weerts, C.² Thieland, J.³ Horst, R.⁴ Harter, H.⁵ Martin, K.⁶

4
- 0024563652
- Parathyroid hormone suppression by intravenous 1,25-dihydroxyvitamin D: A role for increased sensitivity to calcium
- (1989) J Clin Invest , vol.83 , pp. 1349-1355
- Delmez, J.A.¹ Tindira, C.² Grooms, P.³ Dusso, A.S.⁴ Windus, D.W.⁵ Slatopolsky, E.⁶

5
- 0024412717
- Intravenous calcitriol in the treatment of refractory osteitis fibrosa of chronic renal failure
- (1989) N Engl J Med , vol.321 , pp. 274-279
- Andress, D.L.¹ Keith, M.D.² Norris, C.³ Coburn, J.W.⁴ Slatopolsky, E.⁵ Sherrard, D.J.⁶

6
- 0026785324
- Low-dose intravenous calcitriol treatment of secondary hyperparathyroidism in hemodialysis patients
- (1992) Kidney Int , vol.42 , pp. 1191-1198
- Gallieni, M.¹ Brancaccio, D.² Padovese, P.³ Rolla, D.⁴ Bedani, P.⁵ Colantonio, G.⁶ Bronzieri, C.⁷ Bagni, B.⁸ Tarolo, G.⁹

7
- 0015806055
- The influence of a high calcium carbonate intake on bone disease in patients undergoing hemodialysis
- (1973) Kidney Int , vol.4 , pp. 146-153
- Meyrier, A.¹ Marsac, J.² Richet, G.³

8
- 0020668864
- A substitution of aluminum hydroxide by high doses of calcium carbonate in patients on chronic hemodialysis: Disappearance of hyperaluminaemia and equal control of hyperparathyroidism
- (1983) Proc Eur Dial Transplant Assoc , vol.19 , pp. 784-787
- Moriniere, P.¹ Roussel, A.² Tahiri, Y.³ Defremont, J.F.⁴ Maurel, G.⁵ Joudon, M.C.⁶ Gueris, J.⁷ Fournier, A.⁸

9
- 0008119898
- Therapeutically active vitamin D analogs
- (1999) Nephrol Exch , vol.8 , pp. 14-19
- Brown, A.J.¹

10
- 0028866312
- 2 suppresses parathyroid hormone secretion in uremic rats in the absence of hypercalcemia
- (1995) Am J Kidney Dis , vol.26 , pp. 852-860
- Slatopolsky, E.¹ Finch, J.² Ritter, C.³ Denda, M.⁴ Morrissey, J.⁵ Brown, A.J.⁶ DeLuca, H.F.⁷

11
- 0032908545
- 2 on calcium and phosphorus resorption in bone
- (1999) J Am Soc Nephrol , vol.10 , pp. 980-985
- Finch, J.L.¹ Brown, A.J.² Slatopolsky, E.³

12
- 0030837556
- 2, suppresses serum PTH and parathyroid gland growth in uremic rats without elevation of intestinal vitamin D receptor content
- (1997) Am J Kidney Dis , vol.30 , pp. 105-112
- Takahashi, F.¹ Finch, J.² Denda, M.³ Dusso, A.⁴ Brown, A.⁵ Slatopolsky, E.⁶

13
- 0345403572
- 2 (paricalcitol) safety and effectively reduces the levels of intact PTH in patients on hemodialysis
- (1998) J Am Soc Nephrol , vol.10 , pp. 1427-1432
- Martin, K.J.¹ Gonzalez, E.A.² Gellens, M.³ Hamm, L.L.⁴ Abboud, H.⁵ Lindberg, J.⁶

14
- 0021978965
- 3 in the rat
- (1985) Proc Soc Exp Biol Med , vol.178 , pp. 432-436
- Sjoden, G.¹ Smith, C.² Lindgren, U.³ Deluca, H.F.⁴

15
- 17144459471
- 2 in dialysis patients with secondary hyperparathyroidism: A sequential comparison
- (2001) Am J Kidney Dis , vol.37 , pp. 5372-5543
- Maung, H.M.¹ Elangovan, L.² Frazao, J.³

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.